logo

For the Inventor, By the Inventor

Branford, CT, United States of America

Xu Kevin Lin

This inventor holds 6 USPTO granted patents, plus 1 CIPO patent and 2 EPO patents. Top assignees: Vion Pharmaceuticals, Inc., Aria Neurosciences Inc., Nanotherapeutics, Inc.. Active years: 2002-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xu Kevin Lin. Retrieved from https://idiyas.com/inventor/xu-kevin-lin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6

% Patents Active = 66.7



Average Co-Inventor Count = 2.9

ph-index = 2

Forward Citations = 16(Granted Patents)


Location History:

  • Brandford, CT (US) (2005)
  • Branford, CT (US) (2002 - 2014)

Company Filing History:

goldMedal4 out of 17 
 
Vion Pharmaceuticals, Inc.
 patents
silverMedal1 out of 1 
 
Aria Neurosciences Inc.
 patent
bronzeMedal1 out of 16 
 
Nanotherapeutics, Inc.
 patents
4. 1 out of 1,727 
 
New York University
 patents
where one patent can have more than one assignee

Years Active: 2002-2014

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents
1. 8658677 - Pyridyl-2-methylamino compounds, compositions and uses thereof (2014-02-25),
2. 8026395 - Process for the synthesis of anti-neoplasia agent VNP40101M (2011-09-27),
3. 7405317 - Phosphate-bearing prodrugs of sulfonyl hydrazines as hypoxia-selective antineoplastic agents (2008-07-29),
4. 7273714 - Alkylguanyltransferase assays (2007-09-25),
5. 6855695 - Water-soluble SHPs as novel alkylating agents (2005-02-15),
6. 6458816 - Modified prodrug forms of AP/AMP (2002-10-01),

Title: Xu Kevin Lin: Innovator in Pharmaceutical Compounds

Introduction

Xu Kevin Lin is a notable inventor based in Branford, Connecticut, with a significant contribution to the field of pharmaceuticals. He holds a total of six patents, showcasing his innovative approach to developing compounds that address various medical conditions.

Latest Patents

Among his latest patents is the invention of Pyridyl-2-methylamino compounds, compositions, and their uses. These compounds are designed to prevent and treat a variety of conditions in mammals, including Alzheimer's Disease, Down's syndrome, and Parkinson's Disease. Another significant patent is the process for synthesizing the anti-neoplasia agent VNP40101M. This invention outlines simple, safe, and high-yield methods for synthesizing VNP40101M, which is crucial in cancer treatment.

Career Highlights

Xu Kevin Lin has worked with prominent companies in the pharmaceutical industry, including Vion Pharmaceuticals, Inc. and Aria Neurosciences Inc. His work has significantly impacted the development of therapeutic agents, particularly in the realm of neurodegenerative diseases and cancer.

Collaborations

Throughout his career, Xu has collaborated with esteemed colleagues such as Ivan C. King and Terrence W. Doyle, contributing to the advancement of innovative pharmaceutical solutions.

Conclusion

Xu Kevin Lin's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a key innovator. His work continues to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…